China Resources Double-Crane Pharmaceutical Co.,Ltd.
Sector
Industries
Location
Market Cap
USD 2.95 B
Share Price
USD 2.84
Avg Daily Volume
15,356,302
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 701.23
LLY
AbbVie Inc.
USD 206.69
ABBV
Roche Holding AG
USD 331.61
RO.SW
Novartis AG
USD 123.29
NOVN.SW
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 131.75
ABT
Merck & Co., Inc.
USD 84.21
MRK
Amgen Inc.
USD 296.47
AMGN
Pfizer Inc.
USD 25.14
PFE
Sanofi
USD 99.43
SAN.PA
CSL Limited
USD 175.99
CSL.AX
GSK plc
USD 18.80
GSK.L
Zoetis Inc.
USD 154.11
ZTS
Regeneron Pharmaceuticals, Inc.
USD 580.41
REGN
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.83
600276.SS
Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
---|
Eli Lilly and Company
USD 701.23
LLY
AbbVie Inc.
USD 206.69
ABBV
Roche Holding AG
USD 331.61
RO.SW
Novartis AG
USD 123.29
NOVN.SW
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 131.75
ABT
Merck & Co., Inc.
USD 84.21
MRK
Amgen Inc.
USD 296.47
AMGN
Pfizer Inc.
USD 25.14
PFE
Sanofi
USD 99.43
SAN.PA
CSL Limited
USD 175.99
CSL.AX
GSK plc
USD 18.80
GSK.L
Zoetis Inc.
USD 154.11
ZTS
Regeneron Pharmaceuticals, Inc.
USD 580.41
REGN
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.83
600276.SS